Physician profile
Mona Megahed
NPI 1023229143
$741.25
in general payments reported to CMS, 2019-2025
17 companies · $170 in 2025
The $170 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $74.25 · 2020: $59.36 · 2021: $119 · 2022: $217 · 2023: $15.92 · 2024: $85.56 · 2025: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $244 · Long Term Medical Supply Or Device Loan: $27.43.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $243.86 |
| Long Term Medical Supply Or Device Loan | $27.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $100.87 | 2022-2025 | Azstarys |
| Takeda Pharmaceuticals U.S.A., INC. | $98.43 | 2021-2022 | |
| Tris Pharma INC | $78.63 | 2020-2025 | Onyda Xr |
| Abbott Laboratories | $74.25 | 2019 | |
| Sanofi Pasteur INC. | $73.32 | 2022-2025 | |
| Neos Therapeutics, LP | $71.05 | 2020-2024 | Adzenys Xr-Odt |
| Seqirus USA INC | $35.68 | 2021-2025 | Flucelvax |
| Glaxosmithkline, LLC. | $28.41 | 2025 | Bexsero |
| Cranial Technologies, INC | $27.67 | 2020-2021 | |
| Baxter Healthcare | $27.43 | 2024 | Hillrom - Audioscope 3 |
| Ironshore Pharmaceuticals INC. | $24.30 | 2024 | |
| Ars Pharmaceuticals Operations, INC. | $23.98 | 2025 | Neffy |
| Merck Sharp & Dohme LLC | $18.24 | 2022 | |
| Collegium Pharmaceutical, INC. | $17.59 | 2025 | Jornay Pm |
| Alk-Abello, INC | $15.92 | 2023 | Grastek, Ragwitek, Odactra |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $14.06 | 2025 | |
| Kaleo, INC. | $11.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mona Megahed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.